Fundraising FoxAerpio Therapeutics
Cincinnati, US · Founded 2011 · Delaware corporation · 4 known investors
Find your way into Aerpio Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Kenneth Morand, Ph.D. to introduce you to Joseph Gardner
You →Kenneth · together at P&G Pharmaceuticals →Joseph
Sign up to find every way you can get introduced to Aerpio Therapeutics
- Your email: who you already know at Aerpio Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Aerpio Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Aerpio Therapeutics was founded in 2011 by Robert Shalwitz and Joseph Gardner.
Board
Investors · 4
How we know: CincyTech's portfolio page · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$35M disclosed across 4 rounds · 2011–2016
▶$3.5MraisedNov 2016 · 53 investors · BiotechnologyRule 506(b)
- Joseph H. GardnerExecutive Officer, Director
- John RiceDirector
- Paul WeissDirector
- Campbell MurrayDirector
- Duane NashDirector
- Steve PakolaExecutive Officer
- Reinhard AmbrosDirector
- Anupam DalalDirector
- Chau KhuongDirector
- Adrienne GravesDirector
- Kevin PetersExecutive Officer
- Muneer SatterDirector
- Offering amount
- $4.6M
- Amount sold
- $3.5M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$4.5MraisedApr 2016 · 54 investors · BiotechnologyRule 506(b)
- Reinhard AmbrosDirector
- Duane NashDirector
- Paul WeissDirector
- Muneer SatterDirector
- Adrienne GravesDirector
- Joseph H. GardnerExecutive Officer
- Kevin PetersExecutive Officer
- Chau KhuongDirector
- Steve PakolaExecutive Officer
- Anupam DalalDirector
- John RiceDirector
- Campbell MurrayDirector
- Offering amount
- $9.2M
- Amount sold
- $4.5M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$22MraisedMay 2014 · 37 investors · BiotechnologyRule 506(b)
- Campbell MurrayDirector
- Kevin PetersExecutive Officer
- Joseph H. GardnerExecutive Officer, Director
- Paul WeissDirector
- Anupam DalalDirector
- Lauren SilvermanDirector
- Muneer SatterDirector
- Chau KhuongDirector
- Robert ShalwitzExecutive Officer
- Adrienne GravesDirector
- John RiceDirector
- Duane NashDirector
- Offering amount
- $22M
- Amount sold
- $22M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$5MraisedJan 2012 · 24 investors · BiotechnologyRule 506(b)
- Robert ShalwitzExecutive Officer
- John RiceDirector
- Kevin PetersExecutive Officer
- Anupam DalalDirector
- Paul WeissDirector
- Ian A.W. HowesExecutive Officer
- Campbell MurrayDirector
- Joseph H. GardnerExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Aerpio Therapeutics went on to found or lead other companies.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $207.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Aerpio Therapeutics?
- Aerpio Therapeutics was founded by Robert Shalwitz, Joseph Gardner in 2011.
- Who are Aerpio Therapeutics's investors?
- Aerpio Therapeutics's investors include CincyTech, Sofinnova Ventures, Ally Bridge Group, OrbiMed.
- How much funding has Aerpio Therapeutics raised?
- Aerpio Therapeutics has disclosed $35M raised across 4 rounds.
- Where is Aerpio Therapeutics headquartered?
- Aerpio Therapeutics is headquartered in Cincinnati, US.